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Introduction: Gastrointestinal stromal tumor is the most common malignant mesenchymal tumor of the
gastrointestinal tract. The most common sites of metastasis are the liver and the peritoneum, but gastrointestinal
stromal tumors rarely metastasize to the skeletal muscles. Only three cases of gastrointestinal stromal tumor
metastasizing to skeletal muscle have been reported in the English literature. Here we present an additional
case of skeletal muscle metastasis, and the relevant literature is reviewed.
Case presentation: A 54-year-old Japanese man presented with a three-month history of an enlarging mass of
the left buttock. An excisional biopsy was performed and the tumor was diagnosed as a leiomyosarcoma. However,
careful examination of the gastrointestinal tract revealed a tumor located in the small intestine. Surgical resection of
the small intestine tumor was performed; histopathological and immunohistochemical examinations identified it as
a primary gastrointestinal stromal tumor arising from the small intestine. Despite receiving both chemotherapy and
molecular-targeted therapy, our patient died of gastrointestinal bleeding six months after the initial diagnosis.
Conclusions: Because it is a mesenchymal tumor, it is difficult to distinguish a gastrointestinal stromal tumor
metastasis to skeletal muscle from other primary soft tissue sarcomas. Although metastasis of gastrointestinal
stromal tumor to skeletal muscle is rare, the likelihood of finding metastases in these unusual sites is increasing
due to prolonged survival of patients with gastrointestinal stromal tumor after the introduction of imatinib therapy.
We should include metastases of gastrointestinal stromal tumors as differential diagnosis of spindle cell tumor, and
it is necessary to begin appropriate treatment early.
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Gastrointestinal stromal tumors (GISTs) are the most
common malignant mesenchymal tumors of the gastro-
intestinal (GI) tract, and account for 1 to 3% of all malig-
nant GI tumors [1]. The precise cellular origin of GISTs
recently has been proposed to be the intestinal cell of
Cajal, an intestinal pacemaker cell. GISTs are most com-
mon in the stomach (60 to 70 percent), followed by the
small intestine (25 to 35 percent), the colon and rectum
(5 percent), and the esophagus (<2 percent). Based on
a population-based sample from Southern Finland,* Correspondence: yasuda@med.u-toyama.ac.jp
1Department of Orthopaedic Surgery, University of Toyama, 2630 Sugitani,
Toyama, Toyama 930-0194, Japan
4Department of Orthopaedic Surgery, Faculty of Medicine, University of
Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan
Full list of author information is available at the end of the article
© 2014 Suzuki et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Miettinen et al. originally estimated the incidence of
malignant GIST to be four per million and the total
incidence to be approximately 40 per million [2]. To the
best of our knowledge, only three cases of GIST metasta-
sizing to skeletal muscle have been reported in the English
literature [3-5]. Here we present an additional case of
skeletal muscle metastasis, and the relevant literature
is reviewed.
Case presentation
In 2010, three months prior to presentation, a 54-year-old
Japanese man noticed an enlarging mass in the soft tissue
of his left buttock. An excisional biopsy was performed
and the tumor was diagnosed as a leiomyosarcoma
composed of cellular bundles of spindle cells (Figure 1).
Immunohistochemical stains demonstrated that tumor
cells were positive for smooth muscle actin (SMA) andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Histopathological findings of the buttock mass at
open biopsy. Spindle-shaped tumor cells with atypical nuclei have
proliferated. The initial diagnosis is a leiomyosarcoma (hematoxylin
and eosin staining; scale bar, 50μm).
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membrane antigen (EMA). Subsequently, a positron emis-
sion tomography (PET)-computed tomography (CT) scan
was performed. The results showed the existence of mul-
tiple metastatic lesions in the skeletal muscle and the ab-
sence of metastases in the liver, lung, and lymph nodes
(Figure 2). The magnetic resonance (MR) images of the
lumbar area and thigh revealed multiple isointense skeletal
muscle tumors on T1-weighted with heterogeneous high-
signal intensities on T2-weighted images (Figure 3A,B).
Our patient was treated with doxorubicin (20g/m2 day 3),Figure 2 Positron emission tomography-computed tomography
scan. Positron emission tomography-computed tomography scan
shows multiple skeletal muscle metastases in the bilateral thighs.and ifosfamide (2,500g/m2 day 3) chemotherapy. Because
he developed anemia during chemotherapy, a careful
examination of his GI tract was performed, which revealed
a bleeding tumor located in the small intestine. Surgical
resection of the small intestine tumor was performed.
Microscopically, the resected mass was composed of inter-
lacing bundles of spindle and epithelioid mesenchymal
cells with morphological features similar to the previously
described tumors in his buttock. The mitotic index was
10/high-power field (HPF), and the tumor seemed to be a
high-grade spindle cell sarcoma. Immunohistochemical
analysis of the tumor cells revealed focal positivity for
c-KIT and SMA, and negativity for CD34 and S-100
(Figure 4A-D). Based on these features, additional immu-
nohistochemical analyses of the primary buttock tumor
were performed. The buttock tumor cells were negative
for c-KIT, but diffusely positive for platelet-derived growth
factor receptor-α (PDGFRA) and were definitively diag-
nosed as a skeletal muscle metastasis of the primary small
intestine GIST. Although our patient underwent chemo-
therapy with imatinib mesylate, death from GI bleeding
occurred six months after the initial diagnosis.
Discussion
GISTs are defined as pleomorphic mesenchymal tumors
of the GI tract composed of spindle cells, epithelioid
cells, or a combination of both, that express the c-KIT
protein and, in most cases, CD34, as demonstrated by
immunohistochemical staining. However, GISTs negative
for c-KIT comprise 5 percent of all GISTs and contain a
mutation of the PDGFRA gene that was reported to be
related to the oncogenesis of these tumors [6]. Surgical
resection of the local disease is the gold standard therapy.
The goal is complete resection of the disease without
tumor rupture. Tumor size, not negative microscopic sur-
gical margins, determines survival. Complete surgical re-
section is possible in approximately 85 percent of patients,
and 50 percent of patients will develop recurrence or
metastasis following complete resection [7]. The five-year
survival rate is approximately 50 percent, while the me-
dian time to recurrence after resection of primary high-
risk GIST is two years. However, after the introduction of
the molecular-targeted therapy, imatinib, there was a
major improvement in the progression-free survival and
overall survival rates. Nevertheless, GISTs have a high risk
of metastatic relapse.
Skeletal muscle metastasis of carcinoma is relatively
rare. Numerous case reports but few studies or large
case series have been reported regarding this occurrence.
Surov et al. reported a prevalence of 1.2 percent in 5,170
oncology patients. The frequency of skeletal muscle
metastases varied from 0.4 to 4.9 percent for different
primary tumors [8]. The most frequent occurrence of
skeletal muscle metastasis was in patients with carcinoma
Figure 3 Magnetic resonance imaging findings of the paravertebral muscle and left thigh. Axial T2-weighted imaging reveals high-signal
intensity masses in the paravertebral muscle (A) and the left quadriceps (B).
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carcinoma. Skeletal muscle metastases from sarcomas are
extremely rare, as reported by Plaza et al. [9], who con-
ducted the largest study concerning metastases to soft
tissue; 118 patients with metastatic tumors to soft tissue
were identified from a total of 7,237 soft tissue tumors
and were included in their study (1.6 percent of all soft tis-
sue sarcomas assessed during the same period). Of these
118 cases, 11 had metastases of sarcomatoid elements of
primary soft tissue sarcomas from other sites, six had me-
tastases from a uterine leiomyosarcoma, two from bone
osteosarcoma, two from uterine malignant mixed Muller-
ian tumor, and one from ovarian carcinosarcoma. ArpaciFigure 4 Histopathological findings and immunohistochemical stainin
tumor with hypercellularity and spindle-shaped cells. The mitotic index is 7
50μm). Immunohistochemical stain for c-KIT (B) shows diffuse staining of tet al. proposed to define the radiological imaging features
and clinical findings of patients with skeletal muscle me-
tastasis. In their study, the most common source was lung
cancer and the muscles mostly affected by metastatic dis-
ease were the gluteals (15 percent), psoas (8.7 percent),
paravertebral (8.7 percent), rectus abdominis (7.6 percent),
and latissimus dorsi (6.5 percent) [10]. On the other hand,
Bocchino et al. reported that most skeletal muscle metas-
tases were localized in the psoas (33.3 percent), buttock
(33.3 percent), and intercostal muscles (29.6 percent) [11].
Furthermore, Surov et al. showed that most muscle me-
tastases were identified in the iliopsoas (27.5 percent),
paravertebral (25 percent), gluteal (16.3 percent), lowerg of the small intestine tumor. (A) The resected mass shows a
0 per 50 high-power fields (hematoxylin and eosin stain, scale bar:
he cell membrane. CD34 (C) and S-100 (D) staining reveals negativity.
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acic wall (5 percent), and upper extremity (3.8 percent)
muscles [8].
To the best of our knowledge, this case is the fourth
report of skeletal muscle metastases from a GIST
(Table 1) [3-5]. The reports have included two cases of
metastasis to muscle of the thigh, one to paravertebral
muscle, and the current case, to the gluteal muscle.
Although in two of the four cases the GIST had already
metastasized to another site aside from skeletal muscle,
two cases, including ours (cases one and four) were
initially treated as leiomyosarcoma of the uterine or
buttock muscle, respectively. Distinguishing between
skeletal muscle metastases from GISTs and primary
spindle cell sarcoma occurring in skeletal muscle may
be challenging. Of a total of 133 rectal and anal GISTs
identified in the Armed Forces Institute of Pathology
at Washington and in the Haartman Institute of the
University of Helsinki, 80 tumors (60 percent) had been
originally diagnosed in other centers as leiomyosarcoma,
29 (21.8 percent) as smooth muscle tumors of uncertain
malignant potential, 21 (15.8 percent) as leiomyoma and
only three (2.25 percent) as GISTs [12]. Differentiating
metastatic tumor from GIST and primary leiomyosarcoma
in skeletal muscle has often been confusing. Our case was
also, morphologically speaking, a spindle cell sarcoma
with immunoreactivity for SMA.
Early recognition and prompt diagnosis will allow the
proper treatment to be initiated in a timely fashion.
Emmering et al. reported that PET-CT was a sensitive
tool for early detection of skeletal muscle metastases
and for staging malignant disease [13]. Bocchino et al.
reported that 18-fluoro-fluorodeoxyglucose (18F-FDG) up-
take in muscle metastatic lesions increased homoge-
neously reaching a higher maximum standardized uptake
value (SUVmax) (mean value 4.2 ± 2.8) than in the liver
[11]. Surov et al. reported PET/CT findings of skeletal
muscle metastases from different primary tumors [14].
Identified skeletal muscle metastases presented as intra-
muscular focal abdominal activity with SUVs ranging from
2.4 to 25.9, median SUV 7.8. The median size of the
muscle metastases was 2.5cm (0.6 to 6.5cm). In this re-
port, there were no significant correlations between SUV
and size of muscle metastases or significant differencesTable 1 Clinical characteristics of GIST patients with skeletal
Case Reference [No.] Age/Sex Primary site Location of muscle
metastases (years)*
1 Pasku et al. [3] 56/F Pelvic cavity Gluteal muscle (2)
2 Cichowitz et al. [4] 23/F Small intestine Adductor longus (ov
3 Bashir et al. [5] 56/M Small intestine Upper back muscle (
4 Present case 54/M Small intestine Quadriceps (at the in
*Period from the initial diagnosis. GIST, gastrointestinal stromal tumor; DDx, differen
M, male; DOD, died of disease.between SUVs of muscle metastases and primary tumors.
Although MR imaging is not specific for skeletal muscle
metastasis, it is an indispensable tool for diagnosis and
treatment, the results of which clinicians may use to con-
template the general management of these patients. Surov
et al. reported findings of MR imaging of intramuscular
metastases [15]. On T2-weighted images, 97 percent of
the recognized intramuscular metastases were hyperin-
tense and on T1-weighted images, 91 percent of the intra-
muscular metastases were homogeneously isointense,
in comparison to adjacent muscle tissue. The calculated
apparent diffusion coefficient (ADC) values were low or
moderate signal intensity in 94 percent of the intramuscu-
lar metastases.
In the current case, the findings of the MR imaging
were hyperintensity on T2-weighted and isointensity on
T1-weighted images in the identified location of the
skeletal muscle metastasis, and according to the MR im-
aging results, our patient underwent excisional biopsy
and the tumor was misdiagnosed as a leiomyosarcoma.
We should remember to include metastases of GISTs in
the differential diagnosis of spindle cell tumors, and that
it is necessary to begin early and appropriate treatment.Conclusions
In summary, we present an extremely rare case of skeletal
muscle metastasis from a GIST. To the best of our know-
ledge, there have been only three previously reported cases
in the English literature of GIST metastasizing to skeletal
muscle. Although skeletal muscle metastases from GIST
are rare, the likelihood of finding metastases in these
unusual sites has increased due to the prolonged survival
of patients with GIST after the introduction of imatinib
therapy. We should recognize metastases of GISTs in the
differential diagnosis for spindle cell tumors, as it is neces-
sary to begin appropriate treatment in a timely fashion.Consent
Written informed consent was obtained from the pa-
tient’s next-of-kin for publication of this case report and
any accompanying images. A copy of the written consent
is available for review by the Editor-in-Chief of this
journal.muscle metastases




Leiomyosarcoma Lung (1) NED (3)
er 5) GIST Liver (2) AWD (over 5)
within 1) Leiomyosarcoma Cardiac adrenal (1) AWD (1)
itial consultation) Leiomyosarcoma None DOD (0.5)
tial diagnosis; F, female; NED, no evidence of disease; AWD, alive with disease;
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CT: computed tomography; EMA: epithelial membrane antigen;
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